IP Library Granted Patent US 7,262,253
Granted Patent B2
US 7,262,253 · App. 10/727,083 · Granted Aug 28, 2007

Process for the preparation of amphiphilic poly (N-vinyl-2-pyrrolidone) block copolymers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,262,253
App. No.
10/727,083
Granted
Aug 28, 2007
Kind
B2
Abstract

The instant invention provides a two-step polymerization process for preparing amphiphilic poly(N-vinyl-2-pyrrolidone), (PVP)-block-polyester copolymers and other diblock and triblock copolymers consisting of PVP as one block. The block copolymers of the invention can be used as vehicles for drug delivery.

Claims (25)

1. A process for preparing diblock and triblock copolymers comprising the steps of:

(a) performing radical polymerization of N-vinyl-2-pyrrolidone in the presence of a radical initiator, a chain transfer agent and an alcoholic solvent to form hydroxy-terminated poly (N-vinylpyrrolidone) wherein said hydroxy-terminated poly (N-vinylpyrrolidone) is isolated by dissolution and precipitation; and

(b) performing ionic polymerization of monomers or comonomers selected from the group consisting of 3,6-dimethyl-1,4-dioxane-2,5-dione, ε-caprolactone, γ-caprolactone poly(D,L-lactide), poly(D-lactide), poly (L-lactide), poly(ε-caprolactone) and poly (γ-caprolactone) in the presence of a catalyst and a macroinitiator wherein said macroinitiator is the hydroxy-terminated poly (N-vinylpyrrolidone) formed in step (a)thereby preparing said diblock and triblock copolymers, wherein said copolymers self-assemble in polymeric micelles or stabilized nanoparticles in aqueous solution.

2. The process in accordance with claim 1 wherein said alcoholic solvent is selected from the group consisting of methanol, ethanol, isopropyl alcohol, n-propanol, n-butanol, 2-butanol, tert-butanol, 1-pentanol and 2-pentanol.

3. The process in accordance with claim 1 wherein said chain transfer agent is a thiol derivative selected from the group consisting of 2-mercaptoethanol,3-mercapto-1-propanol, 3-mercapto-2-propanol, 4-mercapto-1-butanol, 3-mercapto-2-butanol and 6-mercapto-1-hexanol.

4. The process in accordance with claim 1 wherein said radical initiator is an azo derivative selected from the group consisting of 2,2′-azobis (2-methyl-N-(2-hydroyethyl)-propionamide); 2,2′-azobis(2-methyl-N-[2-(1-hydroxybutyl)] propionamide and 1,1′-azobis(cyclohexane-carbonitrile).

5. The process in accordance with claim 1 wherein said catalyst is aluminum or tin alkoxides.

6. The process in accordance with claim 1 wherein said poly(N-vinylpyrrolidone) formed in step (a) comprises a hydroxyl group on at least one chain end.

7. The process in accordance with claim 1 wherein the solvent for said dissolution is selected from the group consisting of methanol, ethanol, isopropanolisopropyl alcohol, acetone, 2-butanone, 4-methyl-2-pentanone, dichioromethane and tetrahydrofuran.

8. The process in accordance with claim 7 wherein at least two solvents are combined for said dissolution.

9. The process in accordance with claim 1 wherein the solvent for said precipitation is selected from the group consisting of diethyl ether, tert-butyl methyl ether, hexane derivatives, heptane derivatives, ethyl acetate, isopropyl acetate, toluene and xylene derivatives.

10. The process in accordance with claim 9 wherein at least two solvents are combined for said precipitation.

11. The process in accordance with claim 1 wherein said poly (N-vinylpyrrolidone) formed in step (a) is dried under vacuum at a final temperature over 100° C.

12. The process in accordance with claim 1 wherein said poly (N-vinylpyrrolidone) formed in step (a) is dried by azeotropic distillation using an inert organic solvent.

13. The process in accordance with claim 12 wherein said inert organic solvent is selected from the group consisting of toluene, xylene derivatives and hepatane derivatives.

14. The process in accordance with claim 1 wherein said diblock and triblock copolymers are isolated by precipitation using an inert organic solvent.

15. The process in accordance with claim 14 wherein said inert organic solvent is selected from the group consisting of diethyl ether, tert-butyl methyl ether, hexane derivatives, heptane derivatives, ethyl acetate, isopropylacetate, toluene and xylene derivatives.

16. The process in accordance with claim 15 wherein at least two inert organic solvents are combined for said precipitation.

17. The process in accordance with claim 1 wherein said diblock and triblock copolymers are purified by charcoal treatment.

18. The process in accordance with claim 1 wherein said poly(N-vinylpyrrolidone) formed in step (a) has a molecular weight between 1,000 D and 700 kD.

19. The process in accordance with claim 1 wherein said diblock and triblock copolymers have a molecular weight between 2,000 D and 700 kD.

20. The diblock copolymer prepared by the process of claim 1 .

21. The diblock copolymer of claim 20 wherein said diblock copolymer is poly(N-vinylpyrrolidone)-block-poly (D, L-lactide).

22. The triblock copolymer prepared by the process of claim 1 .

23. The triblock copolymer of claim 22 wherein said triblock copolymer is poly(D,L-lactide)-block-poly (N-vinylpyrrolidone)-block-poly (D, L-lactide).

Assignments (29)
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NUMBER PREVIOUSLY RECORDED AT REEL: 67245 FRAME: 714. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Apr 17, 2025
From: PALADIN PHARMA INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 070887/0702 →
SECURITY INTEREST Recorded Jul 22, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068469/0001 →
SECURITY INTEREST Recorded Jul 19, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068461/0692 →
SECURITY INTEREST Recorded Jul 19, 2024
From: ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 068031/0059 →
SECURITY INTEREST Recorded Jul 19, 2024
From: ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068031/0202 →
CHANGE OF NAME Recorded Jun 20, 2024
From: ENDO VENTURES LIMITED
To: ENDO VENTURES UNLIMITED COMPANY
Reel/Frame 067994/0211 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2024
From: PALADIN LABS (BARBADOS) INC.
To: ENDO VENTURES UNLIMITED COMPANY (F/K/A ENDO VENTURES LIMITED)
Reel/Frame 067778/0988 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2024
From: PALADIN LABS EUROPE LIMITED
To: ENDO VENTURES UNLIMITED COMPANY (F/K/A ENDO VENTURES LIMITED)
Reel/Frame 067779/0054 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2024
From: PALADIN PHARMA INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067245/0714 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ENDO GLOBAL AESTHETICS LIMITED; ENDO GLOBAL VENTURES; ENDO VENTURES BERMUDA LIMITED; ENDO VENTURES LIMITED; PALADIN LABS INC.
Reel/Frame 067221/0958 →
RELEASE OF SECURITY INTEREST Recorded Apr 24, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ENDO GLOBAL AESTHETICS LIMITED; ENDO GLOBAL VENTURES; ENDO VENTURES BERMUDA LIMITED; ENDO VENTURES LIMITED; PALADIN LABS INC.
Reel/Frame 067216/0376 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2024
From: PALADIN LABS INC.
To: PALADIN PHARMA INC.
Reel/Frame 067203/0281 →
CHANGE OF NAME Recorded Mar 5, 2024
From: ENDO VENTURES LIMITED
To: ENDO VENTURES UNLIMITED COMPANY
Reel/Frame 066732/0396 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2024
From: ENDO VENTURES UNLIMITED COMPANY
To: OPERAND PHARMACEUTICALS III LIMITED
Reel/Frame 066732/0137 →
CHANGE OF NAME Recorded Mar 5, 2024
From: OPERAND PHARMACEUTICALS III LIMITED
To: ENDO OPERATIONS LIMITED
Reel/Frame 066732/0413 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Sep 17, 2021
From: ENDO VENTURES LIMITED; ENDO GLOBAL VENTURES; PALADIN LABS INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0893 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded May 26, 2020
From: ENDO GLOBAL VENTURES; ENDO VENTURES LIMITED; PALADIN LABS INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 053548/0239 →
MERGER Recorded Mar 21, 2013
From: LABOPHARM INC.
To: PALADIN LABS INC.
Reel/Frame 030062/0821 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2013
From: LABOPHARM INC.
To: CHIMIGEN INC.
Reel/Frame 030060/0673 →
CHANGE OF NAME Recorded Mar 21, 2013
From: CHIMIGEN INC.
To: LABOPHARM INC.
Reel/Frame 030060/0739 →
CHANGE OF NAME Recorded Mar 21, 2013
From: LABOPHARM EUROPE LIMITED
To: PALADIN LABS EUROPE LIMITED
Reel/Frame 030060/0785 →
MERGER Recorded Mar 21, 2013
From: PALADIN LABS (BARBADOS) INC. (COMPANY #30304); LABOPHARM (BARBADOS) LIMITED (COMPANY # 21899)
To: LABOPHARM (BARBADOS) LIMITED (COMPANY # 36646)
Reel/Frame 030060/0794 →
CHANGE OF NAME Recorded Mar 21, 2013
From: LABOPHARM (BARBADOS) LIMITED
To: PALADIN LABS (BARBADOS) INC.
Reel/Frame 030060/0875 →
CHANGE OF ADDRESS FOR ASSIGNEE Recorded Mar 13, 2013
From: LABOPHARM (BARBADOS) LIMITED
To: LABOPHARM (BARBADOS) LIMITED
Reel/Frame 029980/0533 →
CHANGE OF ADDRESS FOR ASSIGNEE (SEE #2) Recorded Dec 2, 2010
From: LABOPHARM (BARBADOS) LIMITED
To: LABOPHARM (BARBADOS) LIMITED; LABOPHARM (BARBADOS) LIMITED
Reel/Frame 025381/0533 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2008
From: WANG, YUAN; LAFRENIERE, JULIE; MEUNIER, JEAN-FRANCOIS; BIBEAU, GENEVIEVE; LEBRUN, FREDERICK; LIU, LU WEI
To: DELMAR CHEMICALS INC.
Reel/Frame 020957/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2008
From: DELMAR CHEMICALS INC.
To: LABOPHARM INC.
Reel/Frame 020957/0833 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2008
From: LABOPHARM INC.
To: LABOPHARM EUROPE LIMITED - PARTIAL INTEREST (ENTIRE INTEREST OWNED BY LABOPHARM INC., LABOPHARM EUROPE LIMITED, AND LABOPHARM (BARBADOS) LIMITED); LABOPHARM (BARBADOS) LIMITED - PARTIAL INTEREST (ENTIRE INTEREST OWNED BY LABOPHARM INC., LABOPHARM EUROPE LIMITED, AND LABOPHARM (BARBADOS) LIMITED)
Reel/Frame 020957/0862 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 4, 2006
From: LUO, LAIBIN; LESSARD, DAVID; GORI, SANDRA; RANGER, MAXIME
To: LABOPHARM, INC.
Reel/Frame 017420/0309 →